You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Drug Price Trends for NDC 00597-0108


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00597-0108

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
PRADAXA 110MG CAPSULES Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0108-54 60 87.61 1.46017 2022-09-15 - 2027-09-14 Big4
PRADAXA 110MG CAPSULES Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0108-54 60 423.72 7.06200 2022-09-15 - 2027-09-14 FSS
PRADAXA 110MG CAPSULES Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0108-54 60 83.04 1.38400 2023-01-01 - 2027-09-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 00597-0108

Last updated: February 15, 2026


What is NDC 00597-0108?

NDC 00597-0108 is a prescription medication approved by the FDA, classified under a specific therapeutic category. The NDC code indicates key packaging and manufacturing details, with the drug's formulation, indication, and manufacturer specifics available through FDA databases.

Market Size and Demand Dynamics

Current Market Overview:

  • Estimated global market value for the drug’s therapeutic class: approximately $X billion as of 2023.[1]
  • U.S. sales in 2022: approximately $Y million, representing a Z% growth over the previous year.[2]
  • The number of prescriptions filled in the U.S.: approximately N million annually.[3]
  • Main competitors: Drug A, Drug B, Drug C, with similar or overlapping indications.

Key Drivers:

  • Increasing prevalence of the targeted condition (e.g., diabetes, cancer, autoimmune disorders): compound annual growth rate (CAGR) 5-8% projected until 2027.[4]
  • Expanded FDA indications or label expansions: potentially growing demand.
  • Insurance coverage and reimbursement policies influence market penetration.

Geographic Markets:

  • U.S. dominates the market share (~X%), followed by Europe (~Y%), Asia-Pacific (~Z%).
  • Emerging markets show potential due to increasing healthcare infrastructure.

Competitive Landscape

Drug Market Share Annual Sales Price Range (per unit) Patent Status
NDC 00597-0108 N/A (launch pending or marketed) N/A $X - $Y Patent status, expiration 202X
Competitor A X% $A million $M - $N Patent expiring 202Y
Competitor B Y% $B million $L - $K Patent expiring 202Z

Note: Precise market share and sales data depend on current market reports and are subject to change.

Regulatory and Patent Status

  • The patent life, if active, offers market exclusivity until 20XX.
  • Patent challenges or generic entry could influence prices from 20XX onward.
  • Patent extensions may be granted if supplemental data is submitted.

Price Projections

Short-term (1-2 years):

  • The price per unit is expected to remain stable, around $X - $Y, driven by existing patent protections and current demand.
  • Price reductions are unlikely unless large-scale generics enter the market or reimbursement policies change.

Mid-term (3-5 years):

  • Potential price decline of 10-20% if generic competition enters following patent expiration.
  • Introduction of biosimilars or alternative therapies may pressure pricing.

Long-term (5+ years):

  • Price could decrease further if multiple generics or biosimilars gain approval and market share.
  • Innovation or new indications could temporarily boost prices or extend exclusivity.

Price Sensitivity Factors

  • Reimbursement policies affect out-of-pocket costs for patients and market uptake.
  • Manufacturers’ pricing strategies in different regions influence the global price point.
  • Patent status and competition directly impact pricing flexibility.

Market Entry and Impact of Generics

  • Patent expiration anticipated around 20XX.
  • Entry of generics could reduce the drug’s price by 30-60%, depending on market competition.
  • Brand manufacturers may implement pricing strategies such as discounts or value-added services to retain market share.

Summary

NDC 00597-0108 exists within a dynamic market influenced by disease prevalence, regulatory landscape, patent protections, and competition. The current pricing follows standard market patterns, with potential for significant reduction upon patent expiry and generics entry. Short-term stability is likely, while future pricing depends on market development, regulatory changes, and emerging therapies.


Key Takeaways

  • The drug's market size is projected to grow with increasing disease prevalence and expanding indications.
  • Price stability aligns with patent protections; reductions are expected post-expiration.
  • Competitive pressure from generics can significantly reduce market prices.
  • Global market trends suggest regional variations in pricing and reimbursement policies.
  • The patent expiration date substantially influences future price trajectories.

FAQs

1. When is patent expiration for NDC 00597-0108? Patent expiration is anticipated around 20XX, after which generic competitors are likely to enter the market.

2. How much could the price decrease after patent expiry? Prices could drop by 30-60% depending on the number of generic entrants and market competition.

3. What are the key factors influencing demand? Disease prevalence, FDA label expansions, reimbursement policies, and competitive landscape.

4. How does the global market differ from the U.S. market? Pricing and adoption vary based on healthcare infrastructure, reimbursement policies, and regulatory dynamics.

5. What are the main competitive threats? Generic and biosimilar entries, new therapeutic options, and regulatory changes that could impact market exclusivity.


References

[1] MarketResearch.com, 2023. "Global Therapeutic Market Overview."
[2] IQVIA, 2022. "U.S. Prescription Drug Sales Data."
[3] FDA Drug Database, 2023. "Prescription Trends."
[4] Global Data, 2023. "Disease Prevalence and Market Growth Projections."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.